www.fdanews.com/articles/81270-strand-and-elan-pharmaceuticals-enter-into-research-collaboration
STRAND AND ELAN PHARMACEUTICALS ENTER INTO RESEARCH COLLABORATION
September 29, 2005
Strand Life Sciences, a Bangalore-based in silico technologies company announced
today that it has entered into a research collaboration with Elan Pharmaceuticals
aimed towards supporting Elan's drug discovery efforts. This collaboration allows
Elan to access Strand's technologies and achieve customized solutions for internal
research programs. The agreement incorporates access to Strand's extensive in
silico technology portfolio including predictive modeling for efficacy and ADMET,
custom library design, QSAR and pharmacophore modeling, structure based drug
design, data and visual mining and consulting experience.
Genetic
Engineering News